# Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder

> **NCT03564132** · PHASE2 · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 38 (actual)

## Conditions studied

- Tourette Disorder
- Tic Disorders

## Interventions

- **DRUG:** Yigansan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03564132
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-16
- **Primary completion:** 2020-08-15
- **Final completion:** 2022-08-31
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03564132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03564132, "Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT03564132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*